REG - Target H'care REIT - Notice of Half Year Results

Target Healthcare ReitAnnouncement

10/03/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220310:nRSJ2707Ea&default-theme=true

RNS Number : 2707E  Target Healthcare REIT PLC  10 March 2022

10 March 2022

Target Healthcare REIT plc and its subsidiaries

("Target Healthcare" or "the Group")

 

Notice of Half Year Results

Target Healthcare (LSE: THRL), the UK listed specialist investor in modern,
purpose-built care homes, will announce its half year results for the six
months ended 31 December 2021 on Wednesday 16 March 2022.

A live webcast for investors and analysts will be held at 10:00 a.m. on the
day of the results. To register for the webcast or for more details, please
contact FTI Consulting at targethealthcare@fticonsulting.com
(mailto:targethealthcare@fticonsulting.com) .

Enquiries:

 

 Target Fund Managers:  Tel: +44 (0)1786 845 912

 Kenneth MacKenzie

 Gordon Bland

 FTI Consulting:        Tel: +44 (0)20 3727 1000

 Dido Laurimore         targethealthcare@fticonsulting.com (mailto:targethealthcare@fticonsulting.com)

 Claire Turvey

 Richard Gotla

 Notes:

UK listed Target Healthcare REIT plc (THRL) is an externally managed Real
Estate Investment Trust which provides shareholders with an attractive level
of income, together with the potential for capital and income growth, from
investing in a diversified portfolio of modern, purpose-built care homes.

The Group's portfolio at 31 December 2021 comprised 98 assets let to 31
tenants with a total value of £870.5 million.

The Group invests in modern, purpose-built care homes that are let to high
quality tenants who demonstrate strong operational capabilities and a strong
care ethos. The Group builds collaborative, supportive relationships with each
of its tenants as it believes working in this way helps raise standards of
care and helps its tenants build sustainable businesses. In turn, that helps
the Group deliver stable returns to its investors.

LEI: 213800RXPY9WULUSBC04

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORBKLLBLXLXBBB